StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.13−0.01 (-0.47%)

Close on Nov 13, 2026Market cap $216.71MP/E –Yield –

AC Immune cash

Cash and short-term investments held at the end of each period.

AC Immune's cash was CHF 27.76M at Jun 30, 2026. For fiscal 2025 it was CHF 26.80M, down 26.1% from the year before. Over ten years it grew -10.0% a year on average. The highest annual figure on record is CHF 193.59M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 26.80M-26.1%
FY2024Dec 31, 2024CHF 36.28M-53.8%
FY2023Dec 31, 2023CHF 78.49M+148.5%
FY2022Dec 31, 2022CHF 31.59M-61.6%
FY2021Dec 31, 2021CHF 82.22M-48.9%
FY2020Dec 31, 2020CHF 160.89M-16.9%
FY2019Dec 31, 2019CHF 193.59M+23.7%
FY2018Dec 31, 2018CHF 156.46M+25.8%
FY2017Dec 31, 2017CHF 124.38M-18.3%
FY2016Dec 31, 2016CHF 152.21M+98.9%
FY2015Dec 31, 2015CHF 76.52M+2214.6%
FY2014Dec 31, 2014CHF 3.31M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026CHF 27.76M-46.2%
Q4 FY2025Dec 31, 2025CHF 26.80M-65.9%
Q2 FY2025Jun 30, 2025CHF 25.72M-35.7%
Q4 FY2024Dec 31, 2024CHF 36.28M+14.8%
Q2 FY2024Jun 30, 2024CHF 51.56M+15.9%
Q4 FY2023Dec 31, 2023CHF 78.49M+24.3%
Q2 FY2023Jun 30, 2023CHF 40.01M-51.3%
Q4 FY2022Dec 31, 2022CHF 31.59M-66.2%
Q3 FY2022Sep 30, 2022CHF 44.50M-72.3%
Q2 FY2022Jun 30, 2022CHF 63.15M-67.4%
Q4 FY2021Dec 31, 2021CHF 82.22M-47.5%
Q3 FY2021Sep 30, 2021CHF 93.58M-24.8%
Q4 FY2020Dec 31, 2020CHF 160.89M+5.7%
Q4 FY2019Dec 31, 2019CHF 193.59M+153.0%
Q4 FY2018Dec 31, 2018CHF 156.46M+4632.7%
Q4 FY2017Dec 31, 2017CHF 124.38M–
Q4 FY2016Dec 31, 2016CHF 152.21M–
Q4 FY2015Dec 31, 2015CHF 76.52M–
Q4 FY2014Dec 31, 2014CHF 3.31M–

More AC Immune figures

See a number that looks wrong?